Consider a turn to TEKTURNA.
Take control with TEKTURNA
TEKTURNA was proven to lower BP in patients with mild to moderate high blood pressure. In clinical studies, 2 different doses of TEKTURNA were compared to placebo (sugar pill). Both of these doses lowered BP better than placebo.
Proven reduction in systolic blood pressure
- Placebo-3 to -10 points
- TEKTURNA150 mg-9 to -13 points
- TEKTURNA300 mg-13 to -16 points
Proven reduction in diastolic blood pressure
- Placebo-3 to -9 points
- TEKTURNA150 mg-8 to -10 points
- TEKTURNA300 mg-9 to -12 points
Do not use TEKTURNA or TEKTURNA HCT with angiotensin receptor blockers (ARBs) or angiotensin-converting enzyme inhibitors (ACEIs) in patients with diabetes because of increased risk of renal impairment, hyperkalemia, and hypotension. TEKTURNA and TEKTURNA HCT are contraindicated in patients with hypersensitivity to any of the components. Because of the HCTZ component, TEKTURNA HCT is contraindicated in patients with anuria or hypersensitivity to sulfonamide-derived drugs like HCTZ.
Hypersensitivity reactions may range from urticaria to anaphylaxis.
TEKTURNA is well tolerated
TEKTURNA was studied vs placebo in more than 6,000 patients to understand how patients would tolerate it. In these studies, TEKTURNA was generally well tolerated. Diarrhea was the most common side effect (2.3%).
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088 or contact Noden Pharma DAC at Safety@nodenpharma.com or 1-844-399-5701.
How TEKTURNA works
TEKTURNA targets a chemical in the body called renin. Renin starts a process in the body that causes your blood vessels to narrow and raises your blood pressure. By reducing the amount of renin that your body produces, TEKTURNA helps:
- Blood Vessels Relax
- Blood Flow More Freely
- Lower Blood Pressure